Notification of Issue, Conversion or Payment up of Unquoted Equity SecuritiesAnnouncement Summary

Entity name

For personal use only

LUMOS DIAGNOSTICS HOLDINGS LIMITED

Date of this announcement Friday April 01, 2022

The +securities the subject of this notification are:

+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX

Total number of +securities to be issued/transferred

ASX +security

+securities to be

code

Security description

issued/transferred

Issue date

LDXAG

OPTION EXPIRING 30-JUN-2025 EX $1.25

321,514

01/04/2022

Refer to next page for full details of the announcement

Total number of

1 / 6

Notification of Issue, Conversion or Payment up of Unquoted Equity SecuritiesPart 1 - Entity and announcement details

For personal use only

1.1 Name of entity

LUMOS DIAGNOSTICS HOLDINGS LIMITED

We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.

1.2 Registered number type ACN

1.3 ASX issuer code LDX

1.4 The announcement isNew announcement

1.5 Date of this announcement 1/4/2022

Registration number 630476970

2 / 6

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 2 - Issue details

2.1 The +securities the subject of this notification are:

+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX

For personal use only

2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which:has an existing ASX security code ("existing class")

3 / 6

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 3B - number and type of +securities the subject of this notification (existing class) where issue has not previously been notified to ASX in an Appendix 3B

For personal use only

ASX +security code and description

LDXAG : OPTION EXPIRING 30-JUN-2025 EX $1.25

Date the +securities the subject of this notification were issued 1/4/2022

Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class

Yes

Were any of the +securities issued to +key management personnel (KMP) or an +associate?

No

Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms

https://lumosdiagnostics.com/wp-content/uploads/2021/07/2229702.pdf

Any other information the entity wishes to provide about the +securities the subject of this notification

Issue details

Number of +securities

321,514

4 / 6

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 4 - +Securities on issue

For personal use only

Following the issue, conversion or payment up of the +securities the subject of this application, the +securities of the entity will comprise:

(A discrepancy in these figures compared to your own may be due to a matter of timing if there is more than one application for quotation/issuance currently with ASX for processing.)

4.1 Quoted +Securities (Total number of each +class of +securities quoted)

Total number ofASX +security code and description

+securities on issue

LDX : ORDINARY FULLY PAID

150,776,978

4.2 Unquoted +Securities (Total number of each +class of +securities issued but not quoted on ASX)

Total number of

ASX +security code and description

+securities on issue

LDXAF : OPTION EXPIRING 01-JUN-2024 EX $1.25

120,000

LDXAH : OPTION EXPIRING 15-NOV-2026 EX $0.80

10,000

LDXAG : OPTION EXPIRING 30-JUN-2025 EX $1.25

3,860,938

LDXAA : OPTION EXPIRING 12-AUG-2026 EX $0.57

8,559,731

LDXAB : OPTION EXPIRING 04-NOV-2026 EX $0.57

457,431

LDXAC : OPTION EXPIRING 02-MAR-2027 EX $0.57

320,202

LDXAD : OPTION EXPIRING 04-MAR-2027 EX $0.57

137,229

LDXAE : OPTION EXPIRING 01-OCT-2027 EX $0.57

853,602

Notification of Issue, Conversion or Payment up of Unquoted

Equity Securities

5 / 6

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Lumos Diagnostics Holdings Ltd. published this content on 01 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 April 2022 03:52:34 UTC.